Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy

Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was...

Supermicro Expands US Manufacturing Capacity and Development of Industry-Leading Total IT Solutions with Third Campus in Silicon Valley

Supermicro...

AIIB Report Urges Infrastructure Development to Prioritize Health, Climate and Nature to Save Lives and Protect Planet

CAPE TOWN, South Africa, March 1, 2025 /PRNewswire/ -- Amid accelerating climate change and an increasingly challenged global health system, a new report from the...

MAIRE AND KAZAKH-BRITISH TECHNICAL UNIVERSITY SIGN MEMORANDUM ON THE DEVELOPMENT OF INTERNATIONAL COOPERATION IN SCIENCE AND EDUCATION TO FOSTER COMPETENCES FOR THE ENERGY TRANSITION

MILAN,...

QMMM Holdings Limited Announces to receive Nasdaq Minimum Bid Price Deficiency Letter

HONG KONG, Feb. 28, 2025 /PRNewswire/ -- QMMM Holdings Limited (Nasdaq: QMMM) (the "Company" or "QMMM Holdings"), a digital media advertising, virtual avatar &...

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of...

Preclinical...

MWC 2025: Top 10 Innovative Highlights from FiberHome

BARCELONA, Spain, Feb. 28, 2025 /PRNewswire/ -- Under the visionary theme "Connecting the Bright Digital Future," FiberHome is set to redefine the boundaries of innovation at...
1...3,9033,9043,905...4,321Page 3,904 of 4,321